These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30137645)

  • 1. Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective.
    Kenna JG; Taskar KS; Battista C; Bourdet DL; Brouwer KLR; Brouwer KR; Dai D; Funk C; Hafey MJ; Lai Y; Maher J; Pak YA; Pedersen JM; Polli JW; Rodrigues AD; Watkins PB; Yang K; Yucha RW;
    Clin Pharmacol Ther; 2018 Nov; 104(5):916-932. PubMed ID: 30137645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery.
    Hafey MJ; Houle R; Tanis KQ; Knemeyer I; Shang J; Chen Q; Baudy A; Monroe J; Sistare FD; Evers R
    Drug Metab Dispos; 2020 Nov; 48(11):1147-1160. PubMed ID: 32943412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats.
    Yang F; Takeuchi T; Tsuneyama K; Yokoi T; Oda S
    Toxicol Sci; 2019 Jul; 170(1):95-108. PubMed ID: 30985903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.
    Ali I; Khalid S; Stieger B; Brouwer KLR
    Mol Pharm; 2019 Mar; 16(3):1406-1411. PubMed ID: 30608704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI.
    Chan R; Benet LZ
    Toxicol Sci; 2018 Apr; 162(2):499-508. PubMed ID: 29272540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
    Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
    Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
    Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Bile Salt Export Pump (BSEP) Inhibition in Membrane Vesicles Using Radioactive and LC/MS-Based Detection Methods.
    Marroquin LD; Bonin PD; Keefer J; Schroeter T
    Curr Protoc Toxicol; 2017 Feb; 71():14.14.1-14.14.20. PubMed ID: 28146280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a Bile Salt Export Pump Knockdown Rat Susceptibility Model to Interrogate Mechanism of Drug-Induced Liver Toxicity.
    Li Y; Evers R; Hafey MJ; Cheon K; Duong H; Lynch D; LaFranco-Scheuch L; Pacchione S; Tamburino AM; Tanis KQ; Geddes K; Holder D; Zhang NR; Kang W; Gonzalez RJ; Galijatovic-Idrizbegovic A; Pearson KM; Lebron JA; Glaab WE; Sistare FD
    Toxicol Sci; 2019 Jul; 170(1):180-198. PubMed ID: 30903168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Concepts in Drug-Induced Bile Salt Export Pump (BSEP) Interference.
    Kenna JG
    Curr Protoc Toxicol; 2014 Aug; 61():23.7.1-15. PubMed ID: 25104267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
    Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
    Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
    Cheng Y; Woolf TF; Gan J; He K
    Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.
    Garzel B; Zhang L; Huang SM; Wang H
    Curr Drug Metab; 2019; 20(8):621-632. PubMed ID: 31288715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP7A1 Gene Induction via SHP-Dependent or Independent Mechanisms can Increase the Risk of Drug-Induced Liver Injury Independently or in Synergy with BSEP Inhibition.
    Niu C; Xie X; Liu R; Liang X; Hu Y; Lai Y
    Drug Metab Dispos; 2024 Apr; 52(5):432-441. PubMed ID: 38485279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk Potential.
    Aleo MD; Shah F; Allen S; Barton HA; Costales C; Lazzaro S; Leung L; Nilson A; Obach RS; Rodrigues AD; Will Y
    Chem Res Toxicol; 2020 Jan; 33(1):223-238. PubMed ID: 31532188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity.
    Jackson JP; Brouwer KR
    Methods Mol Biol; 2019; 1981():75-85. PubMed ID: 31016648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Warner DJ; Chen H; Cantin LD; Kenna JG; Stahl S; Walker CL; Noeske T
    Drug Metab Dispos; 2012 Dec; 40(12):2332-41. PubMed ID: 22961681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in silico identification of human bile salt export pump (ABCB11) inhibitors associated with cholestatic drug-induced liver injury.
    Xi L; Yao J; Wei Y; Wu X; Yao X; Liu H; Li S
    Mol Biosyst; 2017 Jan; 13(2):417-424. PubMed ID: 28092392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).
    Pedersen JM; Matsson P; Bergström CA; Hoogstraate J; Norén A; LeCluyse EL; Artursson P
    Toxicol Sci; 2013 Dec; 136(2):328-43. PubMed ID: 24014644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Morgan RE; Trauner M; van Staden CJ; Lee PH; Ramachandran B; Eschenberg M; Afshari CA; Qualls CW; Lightfoot-Dunn R; Hamadeh HK
    Toxicol Sci; 2010 Dec; 118(2):485-500. PubMed ID: 20829430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.